Artivion, a cardiac and vascular surgery company, posted $123.8 million in revenue for Q3 2026, up 9% from the previous year, driven by strong sales in its On-X mechanical heart valves and aortic stent grafts. Despite the revenue growth, the company reported a net loss of $7.9 million due to higher operating expenses and investments in new product launches, including the upcoming U.S. commercial launch of NEXUS in January 2027. Artivion narrowed its full-year 2026 revenue guidance to $484-$492 million, expecting 8-10% growth, and anticipates adjusted EBITDA between $93-$98 million. The company remains optimistic about its comprehensive aortic arch portfolio and market opportunities worth approximately $330 million annually in the U.S.
Artivion's third quarter 2026 financial results come amid a health sector market where only 16 of 150 US stocks traded on Pluang rose today. For readers following the health sector, here is Pluang's market snapshot as of Nov 06, 2026 04:11 WIB: Natera Inc. (NTRA) fell 23.32% to USD 299.83 with a typical hold time of 14 days and a Pluang order activity of 59% Sell / 41% Buy; Guardant Health Inc. (GH) dropped 23.00% to USD 129.81 with a typical hold time of 9 days; and Inovio Pharmaceuticals Inc. (INO) declined 22.22% to USD 1.26 with a typical hold time of 41 days and a Pluang order activity of 54% Sell / 46% Buy.
The 2026 Global Health Congress in New York gathered over 625 healthcare leaders from 25 countries to discuss innovation, equity, and investment in healthcare. The event featured 350+ startup applications in its Healthcare Shark Tank competition, cro...
Ambarella, an edge AI semiconductor company, announced its third quarter fiscal year 2027 earnings conference call will be held on November 24, 2026, at 1:30 p.m. Pacific Time. The company will release its earnings report after the market closes that...
Cenovus Energy is experiencing a widened discount to light oil, reaching $31.70, which will affect its fourth quarter results in fiscal year 2026. Management attributes this discount expansion mainly to temporary freight costs and is sticking to its ...
U.S. spot Bitcoin ETFs experienced net outflows of $430.20 million on November 5, reversing the previous day's inflows of $74.57 million. Six of the twelve funds, including Fidelity’s FBTC and BlackRock’s IBIT, saw significant withdrawals. Total trad...
Macro analyst Roberto Rios predicts Bitcoin will reach $300,000 during the current market cycle, citing unexpected strength since a June low. He explains that the market is factoring in increased money creation by the Federal Reserve and further weak...
